Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03440697 · ClinicalTrials.gov registry record

Pathogenetic Basis of Aortopathy and Aortic Valve Disease

A clinical trial of Aortic Valve Disease and Thoracic Aortic Aneurysm, sponsored by Yale University.

Active
Registry status
3,000
Enrollment target
2
Study locations

NCT03440697 is a study of Aortic Valve Disease and Thoracic Aortic Aneurysm that is active but no longer recruiting, run by Yale University. The registered enrollment target is 3,000 participants, below the 18,417-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03440697, a study of Aortic Valve Disease and Thoracic Aortic Aneurysm, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
3,000 participants
Enrollment target
2
Study locations

Study Summary

The main purpose of this study is to define the complex genetic and pathogenic basis of thoracic aortic aneurysm (TAA) and other forms of aortopathy and/or aortic valve disease by identifying novel disease-causing genes and by identifying important genetic modifiers for aortic and aortic valve disease severity.

Conditions Studied

Aortic Valve Disease Thoracic Aortic Aneurysm Thoracic Aortic Dissection Thoracic Aortic Disease Aortopathies Thoracic Aortic Rupture Ascending Aortic Disease Descending Aortic Disease Ascending Aortic Aneurysm Descending Aortic Aneurysm

Study Locations (2)

Georgia

  • Childrens Healthcare of Atlanta - Atlanta

Indiana

  • IU School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2015-12-10
Est. Completion 2030-12-31

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03440697

The ClinicalTrials.gov registry entry for NCT03440697 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,417-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (84% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Aortic Valve Disease appearing as the primary indexed condition, and to 0 interventions.

NCT03440697 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Indiana.

Frequently Asked Questions

What is clinical trial NCT03440697 about?

NCT03440697 is a clinical study titled "Pathogenetic Basis of Aortopathy and Aortic Valve Disease". The main purpose of this study is to define the complex genetic and pathogenic basis of thoracic aortic aneurysm (TAA) and other forms of aortopathy and/or aortic valve disease by identifying novel disease-causing genes and by identifying important genetic modifiers for aortic and aortic valve disea...

What is the current status of trial NCT03440697?

This trial is currently active not recruiting. The enrollment target is 3,000 participants. The study started on 2015-12-10. Estimated completion is 2030-12-31.

What conditions does trial NCT03440697 study?

This clinical trial studies the following conditions: Aortic Valve Disease, Thoracic Aortic Aneurysm, Thoracic Aortic Dissection, Thoracic Aortic Disease, Aortopathies.

Who is sponsoring clinical trial NCT03440697?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03440697 being conducted?

This trial has 2 study locations across Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aortic Valve Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aortic Valve Disease

All registered trials for this condition

Thoracic Aortic Aneurysm

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.